Gut Infection in HIV: Past, Present and Future

  • Simon Portsmouth
  • Justin Stebbing
  • Brian Gazzard


Thirty years ago parasitic infection of the gut was an esoteric rarity in the developed world and was chiefly of interest to individuals involved in tropical medi- cine. This was revolutionized by the advent of the AIDS epidemic, when gut infection became a com- mon terminal event and studying parasitic disease became important to reduce symptoms and prolong life. The study of these infections provides an ideal opportunity to tease out the complex host-parasite interaction, which normally leads to the elimination of infection.


Stool Volume Galactosyl Ceramide Cryptosporidial Diarrhoea Acute Human Immunodeficiency Virus Type Specific Immune Tolerance 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nelson, MR, Shanson DC, Hawkins DA, Gazzard BG (1992). Salmonella, Campylobacter and Shigella in HIV-seropositive patients. Aids 6:1495–1498PubMedCrossRefGoogle Scholar
  2. 2.
    Polotsky Y, Nataro JP, Kotier D, Barrett TJ, Orenstein JM (1997) HEp-2 cell adherence patterns, serotyping, and DNA analysis of Escherichia coli isolates from eight patients with AIDS and chronic diarrhea. J Clin Microbiol 35:1952–1958PubMedGoogle Scholar
  3. 3.
    Wanke CA, Gerrior J, Blais V, Mayer H, Acheson D (1998) Successful treatment of diarrheal disease asso-ciated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. J Infect Dis 178:1369–1372PubMedCrossRefGoogle Scholar
  4. 4.
    Orenstein JM, Kotler DP (1995) Diarrheogenic bacter-ial enteritis in acquired immune deficiency syn-drome: a light and electron microscopy study of 52 cases. Hum Pathol 26:481–492PubMedCrossRefGoogle Scholar
  5. 5.
    Albrecht H, Stellbrink HJ, Fenske S, Ermer M, Raedler A, Greten H (1993) Rotavirus antigen detection in patients with HIV infection and diarrhea. Scand J Gastroenterol 28:307–310PubMedCrossRefGoogle Scholar
  6. 6.
    Maddox A, Francis N, Moss J, Blanshard C, Gazzard B (1992) Adenovirus infection of the large bowel in HIV positive patients. J Clin Pathol 45:684–688PubMedCrossRefGoogle Scholar
  7. 7.
    Moyle G, Gazzard BG (1995) Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis. Am J Med 98:319–320PubMedCrossRefGoogle Scholar
  8. 8.
    Gazzard BG, Sharpstone D (1995) Management of diarrhoea in HIV infection. Aids 9[Suppl A]:S213-219Google Scholar
  9. 9.
    Connolly GM, Dryden MS, Shanson DC, Gazzard BG (1988) Cryptosporidial diarrhoea in AIDS and its treatment. Gut 29:593–597PubMedCrossRefGoogle Scholar
  10. 10.
    Neild PJ, Evans DF, Castillo FD, Newson R, Yasaki ET, Wingate DL, Gazzard BG (2001) Effect of octreotide on small intestinal motility in HIV-infected patients with chronic refractory diarrhea. Dig Dis Sci 46:2636–2642PubMedCrossRefGoogle Scholar
  11. 11.
    Miao YM, Awad-El-Kariem FM, Gazzard BG (2002) Opportunistic protozoan diarrhoea. J HIV Ther 7:17–20PubMedGoogle Scholar
  12. 12.
    Yoshida A, Hitomi S, Fukui T, Endo H, Morisawa Y, Kazuyama Y, Osumi K, Oka S, Kimura S (2001) Diag-nosis and monitoring of human cytomegalovirus dis-eases in patients with human immunodeficiency virus infection by use of a real-time PCR assay. Clin Infect Dis 33:1756–1761PubMedCrossRefGoogle Scholar
  13. 13.
    Dieterich DT, Kotler DP, Busch DF, Crumpacker C, Du Mond C, Dearmand B, Buhles W (1993) Ganci-clovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multi-center study. J Infect Dis 167:278–282PubMedCrossRefGoogle Scholar
  14. 14.
    Blanshard C, Shanson DC, Gazzard BG (1997) Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. Int J STD AIDS:124–129Google Scholar
  15. 15.
    Cicirello HG, Kehl KS, Addiss DG, Chusid MJ, Glass RI, Davis JP, Havens PL (1997) Cryptosporidiosis in children during a massive waterborne outbreak in Milwaukee, Wisconsin: clinical, laboratory and epi-demiologic findings. Epidemiol Infect 119:53–60PubMedCrossRefGoogle Scholar
  16. 16.
    DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W (1995) The infectivity of Cryp-tosporidium parvum in healthy volunteers. N Engl J Med 332:855–859PubMedCrossRefGoogle Scholar
  17. 17.
    Blanshard C, Jackson AM, Shanson DC, Francis N, Gazzard BG (1992) Cryptosporidiosis in HIV-seropositive patients. Q J Med 85:813–823PubMedGoogle Scholar
  18. 18.
    Sharpstone D, Phelan M, Gazzard B (2000) Differen-tial metabolic response in AIDS-related chronic pro-tozoal diarrhoea. HIV Med 1, no. 2:102–6CrossRefGoogle Scholar
  19. 19.
    Blanshard C, Francis N, Gazzard BG (1996) Investiga-tion of chronic diarrhoea in acquired immunodefi-ciency syndrome. A prospective study of 155 patients. Gut 39:824–832PubMedCrossRefGoogle Scholar
  20. 20.
    Schuster H, Chiodini PL (2001) Parasitic infections of the intestine. Curr Opin Infect Dis 14:587–591PubMedCrossRefGoogle Scholar
  21. 21.
    Breitenmoser AC, Mathis A, Burgi E, Weber R (1999) High prevalence of Entrocytozoon bieneusi in swine with four genotypes that differ from those identified in humans. Parasitology 118:447–453PubMedCrossRefGoogle Scholar
  22. 22.
    Tzipori S, Carville A, Widmer G, Lackner A (1997) Transmission and establishment of a persistent infec-tion of Enterocytozoon bieneusi derived from a human with AIDS, in simian immunodeficiency virus infected rhesus monkeys. J Infect Dis 175:1016–1020PubMedCrossRefGoogle Scholar
  23. 23.
    Kotler DP, Orenstein JM (1994) Prevalence of intes-tinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation. Am J Gas-troenterol 89:1998–2002Google Scholar
  24. 24.
    Peacock CS, Blanshard C, Tovey DG, Ellis DS, Gaz-zard BG (1991) Histological diagnosis of intestinal microsporidiosis in patients with AIDS. J Clin Pathol 44:558–563PubMedCrossRefGoogle Scholar
  25. 25.
    Thomas PD, Pollok RC, Gazzard BG (1999) Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1:19–24PubMedCrossRefGoogle Scholar
  26. 26.
    Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS (1992) Improved light-microscopical detection of microsporidia spores in stool and duode-nal aspirates. The Enteric Opportunistic Infections Working Group. N Engl J Med 326:161–166PubMedCrossRefGoogle Scholar
  27. 27.
    Blanshard C, Ellis DS, Tovey DG, Dowell S, Gazzard BG (1992) Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. Aids 6:311–313PubMedCrossRefGoogle Scholar
  28. 28.
    Kosek M, Alcantara C, Lima AA, Guerrant RL (2001) Cryptosporidiosis: an update. Lancet Infect Dis 1:262–269PubMedCrossRefGoogle Scholar
  29. 29.
    Chen XM, Keithly JS, Paya CV, LaRusso NF (2002) Cryptosporidiosis. N Engl J Med 346:1723–1731PubMedCrossRefGoogle Scholar
  30. 30.
    Molina JM, Tourneur M, Sarfati C, Chevret S, de Gou-vello A, Gobert JG, Balkan S, Derouin F (2002) Fumagillin treatment of intestinal microsporidiosis. N Engl J Med 346:1963–1969PubMedCrossRefGoogle Scholar
  31. 31.
    Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853–860PubMedCrossRefGoogle Scholar
  32. 32.
    Garnett GP, Bartley L, Grassly NC, Anderson RM (2002) Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings. Nat Med 8:651–654PubMedCrossRefGoogle Scholar
  33. 33.
    Lopez Bernaldo de Quiros JC, Miro JM, Pena JM, Podzamczer D, Alberdi JC, Martinez E, Cosin J, Clara-monte X, Gonzalez J, Domingo P, Casado JL, Ribera E (2001) A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumo-cystis carinii pneumonia after highly active antiretro-viral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98. N Engl J Med 344:159–167PubMedCrossRefGoogle Scholar
  34. 34.
    Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC (1990) Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38–45PubMedGoogle Scholar
  35. 35.
    Macatonia SE, Patterson S, Knight SC (1991) Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunol-ogy 74:399–406Google Scholar
  36. 36.
    Clerici M, Shearer GM (1993) A THi->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107–11PubMedCrossRefGoogle Scholar
  37. 37.
    Clerici M, Shearer GM (1994) The Thi-Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575–581PubMedCrossRefGoogle Scholar
  38. 38.
    Andersson J, Kinloch S, Sonnerborg A, Nilsson J, Fehniger TE, Spetz AL, Behbahani H, Goh LE, McDade H, Gazzard B, Stellbrink H, Cooper D, Perrin L (2002) Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. J Infect Dis 185:1355–1358PubMedCrossRefGoogle Scholar
  39. 39.
    Sheehy AM, Nathan C, Jonathan H, Malim S (2002) Isolation of a human gene that inhibits HIV-i infec-tion and is suppressed by the viral Vif protein. Nature (in press)Google Scholar
  40. 40.
    You X, Mead JR (1998) Characterization of experi-mental Cryptosporidium parvum infection in IFN-gamma knockout mice. Parasitology 117:525–531PubMedCrossRefGoogle Scholar
  41. 41.
    Smith LM, Bonafonte MT, Mead JR (2000) Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium pflrvwra-infected gamma-interferon knockout mice. J Parasitol 86:300–307PubMedGoogle Scholar
  42. 42.
    Lim SG, Lipman MC, Squire S, Pillay D, Gillespie S, Sankey EA, Dhillon AP, Johnson MA, Lee CA, Pounder RE (1993) Audit of endoscopic surveillance biopsy specimens in HIV positive patients with gas-trointestinal symptoms. Gut 34:1429–1432PubMedCrossRefGoogle Scholar
  43. 43.
    Lim SG, Condez A, Poulter LW (1993) Mucosal macrophage subsets of the gut in HIV: decrease in antigen-presenting cell phenotype. Clin Exp Immunol 92:442–447PubMedCrossRefGoogle Scholar
  44. 44.
    Lim SG, Condez A, Lee CA, Johnson MA, Elia C, Poul-ter LW (1993) Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 92:448–454PubMedCrossRefGoogle Scholar
  45. 45.
    Gibbons CL, Ong CS, Miao Y, Casemore DP, Gazzard BG, Awad-El-Kariem FM (2001) PCR-ELISA: a new simplified tool for tracing the source of cryp-tosporidiosis in HIV-positive patients. Parasitol Res 87:1031–1304PubMedGoogle Scholar
  46. 46.
    Miao YM, Hayes PJ, Gotch FM, Barrett MC, Francis ND, Gazzard BG (2002) Elevated mucosal addressin cell adhesion molecule-i expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T cell densi-ties. J Infect Dis 185:1043–1050PubMedCrossRefGoogle Scholar
  47. 47.
    Egen JG, Kuhns MS, Allison JP (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3:611–618PubMedCrossRefGoogle Scholar
  48. 48.
    Schwartz JC, Zhang X, Nathenson SG, Almo SC (2002) Structural mechanisms of costimulation. Nat Immunol 3:427–434PubMedCrossRefGoogle Scholar
  49. 49.
    Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216PubMedCrossRefGoogle Scholar
  50. 50.
    Sieling PA, Modlin RL (2002) Toll-like receptors: mammalian “taste receptors” for a smorgasbord of microbial invaders. Curr Opin Microbiol 5:70–75PubMedCrossRefGoogle Scholar
  51. 51.
    MacDonald TT, Pettersson S (2000) Bacterial regula-tion of intestinal immune responses. Inflamm Bowel Dis 6:116–122PubMedCrossRefGoogle Scholar
  52. 52.
    Srivastava P (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nature Rev Immunol 2:185–194CrossRefGoogle Scholar
  53. 53.
    Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW (2002) Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3:265–271PubMedCrossRefGoogle Scholar
  54. 54.
    Moore DA, Henderson D, Gotch F, Gazzard B (1998) Reversal of abnormalities of neutrophil adhesion molecule expression in HIV infection following pro-tease inhibitor therapy. Aids 12:2083–2084PubMedCrossRefGoogle Scholar
  55. 55.
    Conteas CN, Berlin OG, Lariviere MJ, Pandhumas SS, Speck CE, Porschen R, Nakaya T (1998) Examination of the prevalence and seasonal variation of intestinal microsporidiosis in the stools of persons with chron-ic diarrhea and human immunodeficiency virus infection. Am J Trop Med Hyg 58:559–561PubMedGoogle Scholar
  56. 56.
    Deeks SG, Smith M, Holodniy M, Kahn JO (1997) HIV-i protease inhibitors. A review for clinicians. JAMA 277:145–153PubMedCrossRefGoogle Scholar
  57. 57.
    Foudraine NA, Weverling GJ, van Gool T, Roos MT, de Wolf F, Koopmans PP, van den Broek PJ, Meen-horst PL, van] Leeuwen R, Lange JM, Reiss P (1998) Improvement of chronic diarrhoea in patients with advanced HIV-i infection during potent antiretrovi-ral therapy. Aids 12:35–41PubMedCrossRefGoogle Scholar
  58. 58.
    Miao YM, Awad-El-Kariem FM, Gibbons CL, Gazzard BG (1999) Cryptosporidiosis: eradication or suppres-sion with combination antiretroviral therapy? Aids 13:734–735PubMedCrossRefGoogle Scholar
  59. 59.
    Bini EJ, Cohen J (1999) Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea. Am J Gas-troenterol 94:3553–3559CrossRefGoogle Scholar
  60. 60.
    Wei SC, Hung CC, Chen MY, Wang CY, Chuang CY, Wong JM (2000) Endoscopy in acquired immunode-ficiency syndrome patients with diarrhea and nega-tive stool studies. Gastrointest Endosc 51:427–432PubMedCrossRefGoogle Scholar
  61. 61.
    Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr (1998) Combination drug therapy for cryp-tosporidiosis in AIDS. J Infect Dis 178:900–903PubMedCrossRefGoogle Scholar
  62. 62.
    Sprinz E, Mailman R, Barcellos S, Silbert S, Sches-tatsky G, Bern David D (1998) AIDS-related cryp-tosporidial diarrhoea: an open study with rox-ithromycin. J Antimicrob Chemother 41[Suppl B]:85–91PubMedCrossRefGoogle Scholar
  63. 63.
    Rossignol JF, Hidalgo H, Feregrino M, Higuera F, Gomez WH, Romero JL, Padierna J, Geyne A, Ayers MS (1998) A double-,blind>placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 92:663–666PubMedCrossRefGoogle Scholar
  64. 64.
    Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neutra MR (1991) Transepithelial transport of HIV-i by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr 4:760–765PubMedGoogle Scholar
  65. 65.
    Stahl-Hennig C, Steinman RM, Tenner-Racz K, Pope M, Stolte N, Matz-Rensing K, Grobschupff G, Raschdorff B, Hunsmann G, Racz P (1999) Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 285:1261–1265PubMedCrossRefGoogle Scholar
  66. 66.
    Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gonzalez-Scarano F (1991) Inhibi-tion of entry of HIV-i in neural cell lines by antibod-ies against galactosyl ceramide. Science 253:320–323PubMedCrossRefGoogle Scholar
  67. 67.
    Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC, Lackner AA (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427–431PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • Simon Portsmouth
  • Justin Stebbing
  • Brian Gazzard

There are no affiliations available

Personalised recommendations